147 related articles for article (PubMed ID: 21536545)
1. FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1.
Möller E; Hornick JL; Magnusson L; Veerla S; Domanski HA; Mertens F
Clin Cancer Res; 2011 May; 17(9):2646-56. PubMed ID: 21536545
[TBL] [Abstract][Full Text] [Related]
2. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
[TBL] [Abstract][Full Text] [Related]
4. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
[TBL] [Abstract][Full Text] [Related]
5. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
[TBL] [Abstract][Full Text] [Related]
6. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
7. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
8. Hyalinizing spindle cell tumor with giant rosettes arising in the lung: report of a case with FUS-CREB3L2 fusion transcripts.
Kim L; Yoon YH; Choi SJ; Han JY; Park IS; Kim JM; Chu YC; Kim YJ
Pathol Int; 2007 Mar; 57(3):153-7. PubMed ID: 17295648
[TBL] [Abstract][Full Text] [Related]
9. DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
Matsuyama A; Hisaoka M; Shimajiri S; Hashimoto H
Diagn Mol Pathol; 2008 Dec; 17(4):237-40. PubMed ID: 18382348
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera.
Panagopoulos I; Möller E; Dahlén A; Isaksson M; Mandahl N; Vlamis-Gardikas A; Mertens F
Genes Chromosomes Cancer; 2007 Feb; 46(2):181-91. PubMed ID: 17117415
[TBL] [Abstract][Full Text] [Related]
12. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
13. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
14. Low-grade fibromyxoid sarcoma with prominent giant rosettes and heterotopic ossification.
Hisaoka M; Matsuyama A; Aoki T; Sakamoto A; Yokoyama K
Pathol Res Pract; 2012 Sep; 208(9):557-60. PubMed ID: 22819758
[TBL] [Abstract][Full Text] [Related]
15. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.
Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR
Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.
Rose B; Tamvakopoulos GS; Dulay K; Pollock R; Skinner J; Briggs T; Cannon S
J Orthop Surg Res; 2011 Mar; 6():15. PubMed ID: 21406083
[TBL] [Abstract][Full Text] [Related]
17. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.
Lau PP; Lui PC; Lau GT; Yau DT; Cheung ET; Chan JK
Am J Surg Pathol; 2013 May; 37(5):734-8. PubMed ID: 23588368
[TBL] [Abstract][Full Text] [Related]
18. Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature.
Lee AF; Yip S; Smith AC; Hayes MM; Nielsen TO; O'Connell JX
Hum Pathol; 2011 Nov; 42(11):1804-9. PubMed ID: 21658743
[TBL] [Abstract][Full Text] [Related]
19. Low-grade fibromyxoid sarcoma: an unusual cardiac location.
Ferlosio A; Doldo E; Polisca P; Orlandi A
Cardiovasc Pathol; 2013; 22(3):e15-7. PubMed ID: 23290535
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing epithelioid fibrosarcoma.
Patterson JW; Tchernev G; Chokoeva AA; Wick MR
Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
